Drug Metabolism and Disposition: 22 (4)

July 01, 1994; Volume 22,Issue 4

You have access
Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney.
M I Rivera, L M Hinojosa, B A Hill, S S Lau and T J Monks

Drug Metabolism and Disposition July 1994, 22 (4) 503-510;
You have access
Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
G D Loizou, G Urban, W Dekant and M W Anders

Drug Metabolism and Disposition July 1994, 22 (4) 511-517;
You have access
Disposition of magnolol after intravenous bolus and infusion in rabbits.
T H Tsai, C J Chou and C F Chen

Drug Metabolism and Disposition July 1994, 22 (4) 518-521;
You have access
Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoring.
M L Gargas, R L Norton, D J Paustenbach and B L Finley

Drug Metabolism and Disposition July 1994, 22 (4) 522-529;
You have access
Kinetic interactions of lidocaine, diphenhydramine, and verapamil with diltiazem. A study using isolated perfused rat liver.
M D Hussain, Y K Tam, M R Gray and R T Coutts

Drug Metabolism and Disposition July 1994, 22 (4) 530-536;
You have access
Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats.
J B Watkins, S T Crawford and R A Sanders

Drug Metabolism and Disposition July 1994, 22 (4) 537-543;
You have access
Metabolic chiral inversion of stiripentol in the rat. I. Mechanistic studies.
K Zhang, C Tang, M Rashed, D Cui, F Tombret, H Botte, F Lepage, R H Levy and T A Baillie

Drug Metabolism and Disposition July 1994, 22 (4) 544-553;
You have access
Metabolic chiral inversion of stiripentol in the rat. II. Influence of route of administration.
C Tang, K Zhang, F Lepage, R H Levy and T A Baillie

Drug Metabolism and Disposition July 1994, 22 (4) 554-560;
You have access
Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats.
M Nadai, T Hasegawa, L Wang, O Tagaya and T Nabeshima

Drug Metabolism and Disposition July 1994, 22 (4) 561-565;
You have access
Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes.
Y Li, E Wang, C J Patten, L Chen and C S Yang

Drug Metabolism and Disposition July 1994, 22 (4) 566-571;
You have access
Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1.
C Vage and C K Svensson

Drug Metabolism and Disposition July 1994, 22 (4) 572-577;
You have access
Evidence for new metabolic pathways of chloramphenicol in the duck.
J P Cravedi, M Baradat, L Debrauwer, J Alary, J Tulliez and G Bories

Drug Metabolism and Disposition July 1994, 22 (4) 578-583;
You have access
Theoretical kinetics of sequential metabolism in vitro. Study of the formation of 16 alpha-hydroxyandrostenedione from testosterone by purified rat P450 2C11.
K Sugiyama, K Nagata, J R Gillette and J F Darbyshire

Drug Metabolism and Disposition July 1994, 22 (4) 584-591;
You have access
Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo.
P J Chikhale and R T Borchardt

Drug Metabolism and Disposition July 1994, 22 (4) 592-600;
You have access
Pharmacokinetics of RU44403, an active form of newly developed angiotensin-converting enzyme inhibitor (RU44570) in the rat.
M Hirayama, A Kurihara, T Manabe and Y Hasegawa

Drug Metabolism and Disposition July 1994, 22 (4) 601-606;
You have access
Genetic and developmental diversity of hepatic cytochromes P450. Warfarin and progesterone metabolism by hepatic microsomes from four inbred strains of rat.
S Kitareewan and F G Walz

Drug Metabolism and Disposition July 1994, 22 (4) 607-615;
You have access
Metabolic fate of [3H]-l-menthol in the rat.
T Yamaguchi, J Caldwell and P B Farmer

Drug Metabolism and Disposition July 1994, 22 (4) 616-624;
You have access
Disposition and metabolism of the hypoglycemic agent pioglitazone in rats.
P A Krieter, A E Colletti, G A Doss and R R Miller

Drug Metabolism and Disposition July 1994, 22 (4) 625-630;
You have access
Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs.
S Vickers, C A Duncan, A S Yuan and K P Vyas

Drug Metabolism and Disposition July 1994, 22 (4) 631-636;
You have access
Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma.
C Cussac, E Mounetou, M Rapp, J C Madelmont, J C Maurizis, P Labarre, P Chollet, J L Chabard, D Godeneche and J P Baudry

Drug Metabolism and Disposition July 1994, 22 (4) 637-642;
You have access
Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumors.
J R Bading, E R Sigurdson, R D Finn, S D Yeh, J Ginos, N E Kemeny and S M Larson

Drug Metabolism and Disposition July 1994, 22 (4) 643-650;
You have access
N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes.
S W Huskey, G A Doss, R R Miller, W R Schoen and S H Chiu

Drug Metabolism and Disposition July 1994, 22 (4) 651-658;
You have access
N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells.
S E Huskey, J Magdalou, M Ouzzine, G Siest and S H Chiu

Drug Metabolism and Disposition July 1994, 22 (4) 659-662;
You have access
Induction of murine cytochrome P4503A by the lichen constituents usnic and vulpinic acids.
G J Mannering and J A Shoeman

Drug Metabolism and Disposition July 1994, 22 (4) 663-665;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals